RECRUITING

Rapamycin and Infection-related Illness

Description

Conduct a 6-month observational pilot clinical trial to evaluate the safety, monitor the adverse reactions and observe the preliminary effectiveness of medical treatment with oral rapamycin \[Rapamune (Sirolimus)\] in a total of 15 adults, 18 years and older toward preventing and lowering the severity of infectious disease or infection-related illness. Rapamune (Sirolimus) is not approved by the United States Food and Drug Administration (FDA) to prevent and lessen the severity of infection-related illness or infectious disease. Rapamune (Sirolimus) is approved by the FDA for other indications. The main procedures in the study include: * Blood tests to examine cholesterol, lipids, blood platelet counts, inflammation and infection-related health parameters * Questionnaires to examine brain function, mental health, symptoms, overall health status and quality of life * Electrocardiogram (ECG to measure heart function) * Resting diastolic and systolic blood pressure

Conditions

Infectious Diseases
Talk to us

Related Conditions:

Infectious Diseases

Study Overview

On this page

Study Details

Study overview

Conduct a 6-month observational pilot clinical trial to evaluate the safety, monitor the adverse reactions and observe the preliminary effectiveness of medical treatment with oral rapamycin \[Rapamune (Sirolimus)\] in a total of 15 adults, 18 years and older toward preventing and lowering the severity of infectious disease or infection-related illness. Rapamune (Sirolimus) is not approved by the United States Food and Drug Administration (FDA) to prevent and lessen the severity of infection-related illness or infectious disease. Rapamune (Sirolimus) is approved by the FDA for other indications. The main procedures in the study include: * Blood tests to examine cholesterol, lipids, blood platelet counts, inflammation and infection-related health parameters * Questionnaires to examine brain function, mental health, symptoms, overall health status and quality of life * Electrocardiogram (ECG to measure heart function) * Resting diastolic and systolic blood pressure

Rapamycin Treatment for Prevention of Infection-related Illness

Rapamycin and Infection-related Illness

Condition
Infectious Diseases
Intervention / Treatment

-

Contacts and Locations

Gillette

Hoskinson Health and Wellness Clinic, Gillette, Wyoming, United States, 82718

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Male or Female Adults, 18 years and older
  • * Females of child-bearing age taking birth control medication
  • * Received a Hoskinson Health and Wellness Clinic physician prescription for Rapamune (Sirolimus)
  • * Adults requiring monoclonal antibody or biological treatment
  • * Adults diagnosed with an acute lower respiratory or GI infection within 2 weeks
  • * Adults females who are not taking birth control medication, are pregnant or nursing mothers
  • * Adults reporting severe mental or physical disability
  • * Adults reporting unwillingness to travel to onsite clinical facilities
  • * Adults with any change in chronic disease symptoms or medication within 3 months
  • * Any contraindications to medical treatment with Rapamune (Sirolimus), as outlined in the FDA-approved medication guide

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Hoskinson Health and Wellness Clinic,

William Hoskinson, DO, PRINCIPAL_INVESTIGATOR, Hoskinson Health and Wellness Clinic

Study Record Dates

2026-06